R-pharm
Clinical trials sponsored by R-pharm, explained in plain language.
-
New hope for advanced breast cancer: could a cheaper alternative work just as well?
Disease control OngoingThis study compares a new drug, RPH-051, to the approved drug Perjeta for people with HER2-positive breast cancer that has spread or cannot be removed. Both are given with standard chemotherapy and another targeted therapy. The goal is to see if RPH-051 works as well as Perjeta i…
Phase: PHASE3 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New drug RPH-002 takes on erbitux in head and neck cancer showdown
Disease control OngoingThis study compares a new drug, RPH-002, to the standard drug Erbitux for people with advanced head and neck cancer that has spread or come back. Both drugs are given together with chemotherapy. The goal is to see if RPH-002 works as well as Erbitux at shrinking tumors. About 161…
Phase: PHASE3 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New MS drug RPH-035 goes Head-to-Head with ocrevus in early trial
Disease control OngoingThis study compares a new drug, RPH-035, to the approved drug Ocrevus for people with relapsing or progressive multiple sclerosis. The goal is to see if RPH-035 works similarly in the body and has a similar safety profile. About 180 adults will take part in this early-stage trial…
Phase: PHASE1 • Sponsor: R-Pharm • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC